Stay updated with breaking news from Oncomethylome Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MDxHealth (NASDAQ:MDXH – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it weigh in compared to its rivals? We will compare MDxHealth to related companies based on the strength of its earnings, institutional ownership, valuation, risk, analyst recommendations, dividends and profitability. Insider and Institutional Ownership 12.6% of […]
MDxHealth (NASDAQ:MDXH – Get Rating) is one of 45 public companies in the “Medical laboratories” industry, but how does it weigh in compared to its peers? We will compare MDxHealth to related businesses based on the strength of its profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation. Risk & Volatility MDxHealth has a […]
MDxHealth (NASDAQ:MDXH – Get Rating) and Zicix (OTCMKTS:ZICX – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, earnings, institutional ownership and dividends. Risk & Volatility MDxHealth has a beta of 0.19, suggesting that […]
MDxHealth (NASDAQ:MDXH – Get Rating) is one of 45 publicly-traded companies in the “Medical laboratories” industry, but how does it contrast to its competitors? We will compare MDxHealth to related businesses based on the strength of its valuation, analyst recommendations, earnings, dividends, profitability, risk and institutional ownership. Institutional & Insider Ownership 12.6% of MDxHealth shares […]
MDxHealth (NASDAQ:MDXH – Get Rating) is one of 45 public companies in the “Medical laboratories” industry, but how does it compare to its peers? We will compare MDxHealth to related companies based on the strength of its risk, dividends, valuation, earnings, analyst recommendations, profitability and institutional ownership. Analyst Ratings This is a breakdown of current […]